Peer Review Committee for Experimental Therapeutics (ET)

Areas reviewed

• Isolation, testing, and synthesis of natural products
• Modification and development of drugs
• Toxicity and effectiveness of therapeutic agents and drug delivery systems (including nanotechnology- and microbial-based strategies)
• Molecular imaging for pre-clinical therapeutic development
• Pharmacology/pharmacogenetics/pharmacogenomics
• Gene therapies and gene target validation

Committee members are being determined and will be announced in 2021.